We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 818

Patents Court upholds supplementary protection certificate for a novel enantiomer in Generics UK Limited v Daiichi

  • Bird & Bird
  • -
  • United Kingdom
  • -
  • December 31 2008

Generics (UK) Limited (“GUK”) was unsuccessful in its attempt before the Patents Court (Mr Justice Kitchin) to revoke Daiichi's Supplementary Protection Certificate (“SPC”) in respect of levofloxacin

Pharmaceutical Sector Inquiry Preliminary Report

  • Wragge & Co LLP
  • -
  • European Union
  • -
  • December 19 2008

This analysis is the first in a series relating to the European Commission Pharmaceutical Sector Inquiry Preliminary Report of 28 November 2008

Extension of generic substitution and introduction of a reference price system in 2009

  • Bird & Bird
  • -
  • Finland
  • -
  • December 31 2008

A number of blockbusters will become subject to generic substitution in Finland earlier than in many other European countries, i.e. whilst valid product patents are still in force in other European countries

Europe rules against embryonic stem cells patent

  • Wragge & Co LLP
  • -
  • European Union
  • -
  • January 7 2009

By a landmark decision dated 25 November 2008, the Enlarged Board of Appeal of the European Patent Office (EPO) refused a patent application by Wisconsin Alumni Research Foundation (WARF) (the Appellant) covering the use of human embryonic stem cells (ESCs

EPO Enlarged Board of Appeal rejects patent that requires human embryos for implementation

  • Bird & Bird
  • -
  • United Kingdom
  • -
  • December 31 2008

In its decision of 25 November 2008 the EPO Enlarged Board of Appeal (EBA) considered four questions referred to it by the EPO Technical Board of Appeal concerning a patent application by Wisconsin Alumni Research Foundation (WARF) with claims to “a cell culture comprising primate embryonic stem cells…”

Federal Circuit affirms award of attorneys’ fees for litigation misconduct

  • Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • -
  • USA
  • -
  • April 28 2009

In ICU Medical, Inc. v. Alaris Medical Systems, Inc., No. 08-1077 (Fed. Cir. Mar. 13, 2009), the Federal Circuit held that the district court correctly granted SJ of noninfringement and SJ of invalidity, did not commit clear error in awarding attorneys fees, and did not abuse its discretion in granting Rule 11 sanctionsall in favor of Alaris Medical Systems, Inc. (“Alaris”

Lundbeck v. Cobalt and Ratiopharm

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • January 19 2009

Lundbeck brought a judicial review of the Minister's decision to accept the generic companies' ANDSs for their brand of memantine

AB Hassle v. Apotex

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • February 28 2008

The generic company brought a motion asking the Court to reconsider its decision in two proceedings where prohibition was granted and affirmed by the Federal Court of Appeal

Life sciences patent litigation a summary of calendar year 2007

  • Bird & Bird
  • -
  • United Kingdom
  • -
  • February 28 2008

2007 saw slightly fewer fully contested first instance hearings in the life sciences sector in the English Patents Court on which judgment was given, than the previous year (on which we reported in March 2007

Pharmaceutical sector under European Commission scanner

  • McDermott Will & Emery
  • -
  • European Union
  • -
  • February 28 2008

The European Commission has begun an investigation into the European pharmaceutical industry

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy